Kindred Healthcare (NYSE: KND) reported earnings on Oct. 29. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Sep. 30 (Q3), Kindred Healthcare met expectations on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue increased slightly and GAAP earnings per share grew significantly.

Gross margins dropped, operating margins contracted, net margins grew.

Revenue details
 Kindred Healthcare notched revenue of $1.53 billion. The eight analysts polled by S&P Capital IQ predicted a top line of $1.54 billion on the same basis. GAAP reported sales were 0.8% higher than the prior-year quarter's $1.51 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.21. The eight earnings estimates compiled by S&P Capital IQ predicted $0.26 per share. GAAP EPS of $0.14 for Q3 were 367% higher than the prior-year quarter's $0.03 per share. (The prior-year quarter included $0.02 per share in earnings from discontinued operations.)

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 33.2%, 30 basis points worse than the prior-year quarter. Operating margin was 2.7%, 80 basis points worse than the prior-year quarter. Net margin was 0.5%, 40 basis points better than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $1.57 billion. On the bottom line, the average EPS estimate is $0.43.

Next year's average estimate for revenue is $6.23 billion. The average EPS estimate is $1.48.

Investor sentiment
 The stock has a four-star rating (out of five) at Motley Fool CAPS, with 131 members out of 141 rating the stock outperform, and 10 members rating it underperform. Among 44 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 42 give Kindred Healthcare a green thumbs-up, and two give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Kindred Healthcare is hold, with an average price target of $12.00.